Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 7.17 Million USD | 24.49% |
| 2023 | 5.76 Million USD | 12.47% |
| 2022 | 5.12 Million USD | 13.22% |
| 2021 | 4.52 Million USD | -35.96% |
| 2020 | 7.06 Million USD | 41.38% |
| 2019 | 4.99 Million USD | 108.95% |
| 2018 | 2.39 Million USD | -12.51% |
| 2017 | 2.73 Million USD | 419.77% |
| 2016 | 526 Thousand USD | 158.31% |
| 2015 | -902 Thousand USD | -10.81% |
| 2014 | -814 Thousand USD | 57.04% |
| 2013 | -1.89 Million USD | -38.83% |
| 2012 | -1.36 Million USD | -142.08% |
| 2011 | 3.24 Million USD | 200.43% |
| 2010 | -3.23 Million USD | -116.49% |
| 2009 | -1.49 Million USD | -427.19% |
| 2008 | 456 Thousand USD | -45.84% |
| 2007 | 842 Thousand USD | -26.53% |
| 2006 | 1.14 Million USD | -50.0% |
| 2005 | 2.29 Million USD | 25.04% |
| 2004 | 1.83 Million USD | 499.02% |
| 2003 | 306 Thousand USD | 114.33% |
| 2002 | -2.13 Million USD | -75.14% |
| 2001 | -1.21 Million USD | -132.68% |
| 2000 | 3.73 Million USD | 136.38% |
| 1999 | -10.25 Million USD | -839.5% |
| 1998 | 1.38 Million USD | 1286.61% |
| 1997 | 100 Thousand USD | -96.0% |
| 1996 | 2.5 Million USD | 177.78% |
| 1995 | 900 Thousand USD | 12.5% |
| 1994 | 800 Thousand USD | 900.0% |
| 1993 | -100 Thousand USD | -120.0% |
| 1992 | 500 Thousand USD | 600.0% |
| 1991 | -100 Thousand USD | -133.33% |
| 1990 | 300 Thousand USD | 400.0% |
| 1989 | -100 Thousand USD | 92.86% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 2.21 Million USD | 184.81% |
| 2024 Q2 | 777 Thousand USD | -57.61% |
| 2024 Q1 | 1.83 Million USD | 13.85% |
| 2024 FY | 7.17 Million USD | 24.49% |
| 2024 Q4 | 2.35 Million USD | 6.24% |
| 2023 Q2 | 1.13 Million USD | 19.68% |
| 2023 Q4 | 1.61 Million USD | -22.03% |
| 2023 Q1 | 950 Thousand USD | -19.63% |
| 2023 FY | 5.76 Million USD | 12.47% |
| 2023 Q3 | 2.06 Million USD | 81.62% |
| 2022 Q1 | 1.31 Million USD | 123.39% |
| 2022 Q4 | 1.18 Million USD | 15.77% |
| 2022 Q3 | 1.02 Million USD | -36.27% |
| 2022 Q2 | 1.6 Million USD | 21.55% |
| 2022 FY | 5.12 Million USD | 13.22% |
| 2021 Q1 | 1.54 Million USD | -29.69% |
| 2021 Q2 | 521 Thousand USD | -66.37% |
| 2021 Q4 | 590 Thousand USD | -68.36% |
| 2021 Q3 | 1.86 Million USD | 257.97% |
| 2021 FY | 4.52 Million USD | -35.96% |
| 2020 FY | 7.06 Million USD | 41.38% |
| 2020 Q3 | 1.7 Million USD | 2.16% |
| 2020 Q2 | 1.66 Million USD | 11.87% |
| 2020 Q1 | 1.49 Million USD | 26.25% |
| 2020 Q4 | 2.2 Million USD | 29.28% |
| 2019 Q3 | 897 Thousand USD | -24.81% |
| 2019 FY | 4.99 Million USD | 108.95% |
| 2019 Q4 | 1.18 Million USD | 31.66% |
| 2019 Q1 | 1.72 Million USD | 223.6% |
| 2019 Q2 | 1.19 Million USD | -30.96% |
| 2018 Q2 | 347 Thousand USD | -59.74% |
| 2018 Q4 | 534 Thousand USD | -15.51% |
| 2018 Q3 | 632 Thousand USD | 82.13% |
| 2018 FY | 2.39 Million USD | -12.51% |
| 2018 Q1 | 862 Thousand USD | 4.61% |
| 2017 Q3 | 1.34 Million USD | 401.12% |
| 2017 Q4 | 824 Thousand USD | -38.87% |
| 2017 FY | 2.73 Million USD | 419.77% |
| 2017 Q1 | 293 Thousand USD | 47.98% |
| 2017 Q2 | 269 Thousand USD | -8.19% |
| 2016 FY | 526 Thousand USD | 158.31% |
| 2016 Q4 | 198 Thousand USD | 296.0% |
| 2016 Q2 | 396 Thousand USD | 432.77% |
| 2016 Q3 | 50 Thousand USD | -87.37% |
| 2016 Q1 | -119 Thousand USD | -270.0% |
| 2015 FY | -902 Thousand USD | -10.81% |
| 2015 Q1 | -189 Thousand USD | -1081.25% |
| 2015 Q2 | -393 Thousand USD | -107.94% |
| 2015 Q4 | 70 Thousand USD | 117.95% |
| 2015 Q3 | -390 Thousand USD | 0.76% |
| 2014 FY | -814 Thousand USD | 57.04% |
| 2014 Q4 | -16 Thousand USD | 96.35% |
| 2014 Q3 | -438 Thousand USD | -16.49% |
| 2014 Q2 | -376 Thousand USD | -1890.48% |
| 2014 Q1 | 21 Thousand USD | 103.03% |
| 2013 FY | -1.89 Million USD | -38.83% |
| 2013 Q3 | -771 Thousand USD | -102.89% |
| 2013 Q2 | -380 Thousand USD | -630.77% |
| 2013 Q1 | -52 Thousand USD | 93.51% |
| 2013 Q4 | -692 Thousand USD | 10.25% |
| 2012 Q3 | -672 Thousand USD | -138.3% |
| 2012 FY | -1.36 Million USD | -142.08% |
| 2012 Q4 | -801 Thousand USD | -19.2% |
| 2012 Q2 | -282 Thousand USD | -161.71% |
| 2012 Q1 | 457 Thousand USD | -59.7% |
| 2011 FY | 3.24 Million USD | 200.43% |
| 2011 Q1 | 405 Thousand USD | 110.1% |
| 2011 Q2 | 571 Thousand USD | 40.99% |
| 2011 Q3 | 1.13 Million USD | 98.42% |
| 2011 Q4 | 1.13 Million USD | 0.09% |
| 2010 Q3 | 409 Thousand USD | 209.85% |
| 2010 Q4 | -4 Million USD | -1079.95% |
| 2010 Q2 | 132 Thousand USD | -44.3% |
| 2010 FY | -3.23 Million USD | -116.49% |
| 2010 Q1 | 237 Thousand USD | -0.84% |
| 2009 Q1 | -156 Thousand USD | 79.82% |
| 2009 Q2 | 93 Thousand USD | 159.62% |
| 2009 FY | -1.49 Million USD | -427.19% |
| 2009 Q3 | -1.66 Million USD | -1893.55% |
| 2009 Q4 | 239 Thousand USD | 114.33% |
| 2008 FY | 456 Thousand USD | -45.84% |
| 2008 Q2 | 501 Thousand USD | -3.65% |
| 2008 Q3 | 208 Thousand USD | -58.48% |
| 2008 Q4 | -773 Thousand USD | -471.63% |
| 2008 Q1 | 520 Thousand USD | 40.16% |
| 2007 Q4 | 371 Thousand USD | 5.7% |
| 2007 Q1 | 427 Thousand USD | 82.48% |
| 2007 FY | 842 Thousand USD | -26.53% |
| 2007 Q2 | -296 Thousand USD | -169.32% |
| 2007 Q3 | 351 Thousand USD | 218.58% |
| 2006 Q4 | 234 Thousand USD | 2825.0% |
| 2006 Q3 | 8000.00 USD | -98.39% |
| 2006 Q2 | 496 Thousand USD | 21.57% |
| 2006 Q1 | 408 Thousand USD | -57.05% |
| 2006 FY | 1.14 Million USD | -50.0% |
| 2005 FY | 2.29 Million USD | 25.04% |
| 2005 Q1 | 698 Thousand USD | -1.13% |
| 2005 Q2 | 303 Thousand USD | -56.59% |
| 2005 Q3 | 341 Thousand USD | 12.54% |
| 2005 Q4 | 950 Thousand USD | 178.59% |
| 2004 Q3 | 400 Thousand USD | 1.78% |
| 2004 Q2 | 393 Thousand USD | 17.31% |
| 2004 Q4 | 706 Thousand USD | 76.5% |
| 2004 FY | 1.83 Million USD | 499.02% |
| 2004 Q1 | 335 Thousand USD | 59.52% |
| 2003 Q1 | -2000.00 USD | 99.87% |
| 2003 FY | 306 Thousand USD | 114.33% |
| 2003 Q4 | 210 Thousand USD | 98.11% |
| 2003 Q3 | 106 Thousand USD | 1425.0% |
| 2003 Q2 | -8000.00 USD | -300.0% |
| 2002 Q3 | -161 Thousand USD | 65.52% |
| 2002 Q4 | -1.48 Million USD | -821.74% |
| 2002 FY | -2.13 Million USD | -75.14% |
| 2002 Q1 | -24 Thousand USD | 98.83% |
| 2002 Q2 | -467 Thousand USD | -1845.83% |
| 2001 Q2 | 260.7 Thousand USD | -73.19% |
| 2001 Q3 | -421 Thousand USD | -261.48% |
| 2001 FY | -1.21 Million USD | -132.68% |
| 2001 Q4 | -2.05 Million USD | -389.07% |
| 2001 Q1 | 972.25 Thousand USD | -7.67% |
| 2000 Q3 | 830 Thousand USD | -40.71% |
| 2000 FY | 3.73 Million USD | 136.38% |
| 2000 Q4 | 1.05 Million USD | 26.87% |
| 2000 Q2 | 1.4 Million USD | 250.0% |
| 2000 Q1 | 400 Thousand USD | 105.51% |
| 1999 Q2 | -1.1 Million USD | -10.0% |
| 1999 Q4 | -7.25 Million USD | -625.4% |
| 1999 Q3 | -1 Million USD | 9.09% |
| 1999 Q1 | -1 Million USD | -368.63% |
| 1999 FY | -10.25 Million USD | -839.5% |
| 1998 FY | 1.38 Million USD | 1286.61% |
| 1998 Q1 | 800 Thousand USD | 60.0% |
| 1998 Q2 | 700 Thousand USD | -12.5% |
| 1998 Q3 | 100 Thousand USD | -85.71% |
| 1998 Q4 | -213.39 Thousand USD | -313.39% |
| 1997 Q4 | 500 Thousand USD | 183.33% |
| 1997 Q2 | 200 Thousand USD | 200.0% |
| 1997 Q1 | -200 Thousand USD | -133.33% |
| 1997 Q3 | -600 Thousand USD | -400.0% |
| 1997 FY | 100 Thousand USD | -96.0% |
| 1996 Q1 | 600 Thousand USD | 50.0% |
| 1996 Q3 | 800 Thousand USD | 60.0% |
| 1996 FY | 2.5 Million USD | 177.78% |
| 1996 Q4 | 600 Thousand USD | -25.0% |
| 1996 Q2 | 500 Thousand USD | -16.67% |
| 1995 Q3 | 100 Thousand USD | -50.0% |
| 1995 Q4 | 400 Thousand USD | 300.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | -66.67% |
| 1995 FY | 900 Thousand USD | 12.5% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q3 | 100 Thousand USD | -66.67% |
| 1994 Q4 | 300 Thousand USD | 200.0% |
| 1994 FY | 800 Thousand USD | 900.0% |
| 1994 Q1 | 200 Thousand USD | 140.0% |
| 1993 Q3 | 200 Thousand USD | 100.0% |
| 1993 FY | -100 Thousand USD | -120.0% |
| 1993 Q4 | -500 Thousand USD | -350.0% |
| 1993 Q1 | 100 Thousand USD | -83.33% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | -91.67% |
| 1992 FY | 500 Thousand USD | 600.0% |
| 1992 Q4 | 600 Thousand USD | 500.0% |
| 1992 Q1 | 1.1 Million USD | 168.75% |
| 1992 Q2 | 1.2 Million USD | 9.09% |
| 1991 Q1 | 500 Thousand USD | 135.71% |
| 1991 Q2 | 500 Thousand USD | 0.0% |
| 1991 FY | -100 Thousand USD | -133.33% |
| 1991 Q3 | 600 Thousand USD | 20.0% |
| 1991 Q4 | -1.6 Million USD | -366.67% |
| 1990 Q4 | -1.4 Million USD | -333.33% |
| 1990 FY | 300 Thousand USD | 400.0% |
| 1990 Q2 | 500 Thousand USD | -16.67% |
| 1990 Q1 | 600 Thousand USD | 137.5% |
| 1990 Q3 | 600 Thousand USD | 20.0% |
| 1989 Q4 | -1.6 Million USD | -500.0% |
| 1989 Q1 | 600 Thousand USD | 117.65% |
| 1989 Q2 | 500 Thousand USD | -16.67% |
| 1989 FY | -100 Thousand USD | 92.86% |
| 1989 Q3 | 400 Thousand USD | -20.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 112.438% |
| AngioDynamics, Inc. | -97.71 Million USD | 107.341% |
| AtriCure, Inc. | -26.68 Million USD | 126.882% |
| Avinger, Inc. | -16.63 Million USD | 143.12% |
| Azenta, Inc. | -73.12 Million USD | 109.809% |
| BioLife Solutions, Inc. | -70.82 Million USD | 110.128% |
| The Cooper Companies, Inc. | 533.1 Million USD | 98.654% |
| Daxor Corporation | -177.07 Thousand USD | 4150.826% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 147.466% |
| Femasys Inc. | -14.5 Million USD | 149.44% |
| GlucoTrack, Inc. | -7.1 Million USD | 200.971% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -278.722% |
| Hologic, Inc. | 882.6 Million USD | 99.187% |
| ICU Medical, Inc. | 22.82 Million USD | 68.574% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 99.594% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 169.844% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 80.656% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 203.948% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 203.948% |
| Masimo Corporation | 136.5 Million USD | 94.745% |
| Microbot Medical Inc. | -9.85 Million USD | 172.785% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 51.121% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 94.213% |
| Nephros, Inc. | -1.59 Million USD | 550.282% |
| NovoCure Limited | -232.87 Million USD | 103.08% |
| NEXGEL, Inc. | -3.47 Million USD | 306.299% |
| NEXGEL, Inc. | -3.47 Million USD | 306.299% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 106.978% |
| OraSure Technologies, Inc. | 54.07 Million USD | 86.736% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 116.462% |
| Predictive Oncology Inc. | -13.92 Million USD | 151.525% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 363.294% |
| QuidelOrtho Corporation | 139.1 Million USD | 94.843% |
| Repligen Corporation | 54.57 Million USD | 86.857% |
| Sanara MedTech Inc. | -4.21 Million USD | 270.172% |
| STAAR Surgical Company | 28.09 Million USD | 74.471% |
| Sharps Technology, Inc. | -10.12 Million USD | 170.833% |
| Utah Medical Products, Inc. | 16.77 Million USD | 57.245% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 108.439% |
| Jin Medical International Ltd. | 2.86 Million USD | -150.169% |